
Company Number
06233700
Next Accounts
Dec 2025
Shareholders
chrysalis hb holdings ltd
Group Structure
View All
Industry
Management consultancy activities (other than financial management)
+1Registered Address
creation house, 50-72 gauntley street, nottingham, NG7 5HF
Website
http://chrysalisweb.comPomanda estimates the enterprise value of CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD at £2.9m based on a Turnover of £5.1m and 0.58x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD at £659.5k based on an EBITDA of £148.9k and a 4.43x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD at £5.3m based on Net Assets of £2.3m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Chrysalis Health & Beauty Business Solutions Ltd is a live company located in nottingham, NG7 5HF with a Companies House number of 06233700. It operates in the manufacture of other food products n.e.c. sector, SIC Code 10890. Founded in May 2007, it's largest shareholder is chrysalis hb holdings ltd with a 100% stake. Chrysalis Health & Beauty Business Solutions Ltd is a established, mid sized company, Pomanda has estimated its turnover at £5.1m with high growth in recent years.
Pomanda's financial health check has awarded Chrysalis Health & Beauty Business Solutions Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £5.1m, make it smaller than the average company (£12.4m)
- Chrysalis Health & Beauty Business Solutions Ltd
£12.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 19%, show it is growing at a faster rate (10.2%)
- Chrysalis Health & Beauty Business Solutions Ltd
10.2% - Industry AVG
Production
with a gross margin of 42.1%, this company has a comparable cost of product (42.1%)
- Chrysalis Health & Beauty Business Solutions Ltd
42.1% - Industry AVG
Profitability
an operating margin of 0.9% make it less profitable than the average company (6.4%)
- Chrysalis Health & Beauty Business Solutions Ltd
6.4% - Industry AVG
Employees
with 41 employees, this is below the industry average (53)
41 - Chrysalis Health & Beauty Business Solutions Ltd
53 - Industry AVG
Pay Structure
on an average salary of £44.5k, the company has an equivalent pay structure (£44.5k)
- Chrysalis Health & Beauty Business Solutions Ltd
£44.5k - Industry AVG
Efficiency
resulting in sales per employee of £123.9k, this is less efficient (£172.5k)
- Chrysalis Health & Beauty Business Solutions Ltd
£172.5k - Industry AVG
Debtor Days
it gets paid by customers after 59 days, this is near the average (55 days)
- Chrysalis Health & Beauty Business Solutions Ltd
55 days - Industry AVG
Creditor Days
its suppliers are paid after 50 days, this is slower than average (34 days)
- Chrysalis Health & Beauty Business Solutions Ltd
34 days - Industry AVG
Stock Days
it holds stock equivalent to 107 days, this is more than average (35 days)
- Chrysalis Health & Beauty Business Solutions Ltd
35 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 48 weeks, this is more cash available to meet short term requirements (17 weeks)
48 weeks - Chrysalis Health & Beauty Business Solutions Ltd
17 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 20.8%, this is a lower level of debt than the average (54.6%)
20.8% - Chrysalis Health & Beauty Business Solutions Ltd
54.6% - Industry AVG
Chrysalis Health & Beauty Business Solutions Ltd's latest turnover from March 2024 is estimated at £5.1 million and the company has net assets of £2.3 million. According to their latest financial statements, Chrysalis Health & Beauty Business Solutions Ltd has 41 employees and maintains cash reserves of £489 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 41 | 41 | 32 | 29 | 23 | 16 | 16 | 12 | 10 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 623,903 | 720,957 | 726,314 | 518,272 | 559,369 | 602,461 | 492,031 | 498,492 | 416,286 | 207,391 | 217,069 | 192,413 | 6,594 | 2,197 | 2,031 |
Intangible Assets | |||||||||||||||
Investments & Other | 102,840 | 102,840 | 102,840 | 102,840 | 102,840 | 102,840 | 102,840 | 102,840 | 102,840 | ||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 726,743 | 823,797 | 829,154 | 621,112 | 662,209 | 705,301 | 594,871 | 601,332 | 519,126 | 207,391 | 217,069 | 192,413 | 6,594 | 2,197 | 2,031 |
Stock & work in progress | 866,295 | 692,189 | 512,780 | 375,928 | 229,920 | 188,395 | 182,891 | 143,606 | 143,606 | 153,022 | 175,856 | ||||
Trade Debtors | 821,989 | 1,155,617 | 794,843 | 543,805 | 303,434 | 276,915 | 500,339 | 596,453 | 323,797 | 378,422 | 267,348 | 96,612 | 62,981 | 45,795 | 25,636 |
Group Debtors | |||||||||||||||
Misc Debtors | 29,171 | 20,853 | 66,540 | 1,745 | 3,934 | 57,458 | 1,763 | ||||||||
Cash | 488,954 | 262,950 | 257,747 | 1,048,904 | 454,637 | 719,566 | 545,084 | 485,470 | 557,380 | 485,101 | 413,323 | 176,113 | 158,675 | 76,573 | 54,159 |
misc current assets | 561 | 561 | 1,500 | ||||||||||||
total current assets | 2,206,409 | 2,131,609 | 1,631,910 | 1,968,637 | 989,736 | 1,188,810 | 1,285,772 | 1,225,529 | 1,024,783 | 1,016,545 | 857,088 | 273,286 | 224,919 | 122,368 | 79,795 |
total assets | 2,933,152 | 2,955,406 | 2,461,064 | 2,589,749 | 1,651,945 | 1,894,111 | 1,880,643 | 1,826,861 | 1,543,909 | 1,223,936 | 1,074,157 | 465,699 | 231,513 | 124,565 | 81,826 |
Bank overdraft | 35,809 | 22,474 | 96,008 | 22,922 | |||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 403,855 | 473,833 | 350,880 | 339,293 | 182,507 | 87,065 | 163,343 | 154,031 | 186,247 | 337,945 | 146,106 | 23,222 | 14,907 | 43,275 | 38,015 |
Group/Directors Accounts | 83,000 | 43,000 | 18,217 | ||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 124,399 | 106,460 | 84,591 | 304,217 | 76,087 | 296,272 | 402,043 | 363,831 | 283,631 | 154,868 | 57,014 | 51,538 | |||
total current liabilities | 528,254 | 580,293 | 435,471 | 643,510 | 341,594 | 462,146 | 587,860 | 613,870 | 511,017 | 337,945 | 300,974 | 80,236 | 66,445 | 43,275 | 38,015 |
loans | 6,000 | 22,292 | 143,443 | 144,314 | 39,549 | ||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 44,304 | 45,398 | 46,492 | 47,586 | 49,127 | 28,524 | 19,831 | ||||||||
provisions | 36,192 | 52,369 | 48,859 | 28,818 | 1,175 | 12,953 | 12,953 | 12,953 | 20,546 | 6,092 | 6,315 | 1,362 | 1,172 | ||
total long term liabilities | 80,496 | 97,767 | 95,351 | 76,404 | 50,302 | 12,953 | 18,953 | 12,953 | 20,546 | 28,384 | 149,758 | 145,676 | 40,721 | 28,524 | 19,831 |
total liabilities | 608,750 | 678,060 | 530,822 | 719,914 | 391,896 | 475,099 | 606,813 | 626,823 | 531,563 | 366,329 | 450,732 | 225,912 | 107,166 | 71,799 | 57,846 |
net assets | 2,324,402 | 2,277,346 | 1,930,242 | 1,869,835 | 1,260,049 | 1,419,012 | 1,273,830 | 1,200,038 | 1,012,346 | 857,607 | 623,425 | 239,787 | 124,347 | 52,766 | 23,980 |
total shareholders funds | 2,324,402 | 2,277,346 | 1,930,242 | 1,869,835 | 1,260,049 | 1,419,012 | 1,273,830 | 1,200,038 | 1,012,346 | 857,607 | 623,425 | 239,787 | 124,347 | 52,766 | 23,980 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 105,862 | 188,083 | 140,949 | 93,581 | 79,146 | 57,874 | 70,349 | 55,031 | 45,415 | 10,661 | 6,721 | 4,029 | 2,031 | 2,065 | 1,798 |
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | 174,106 | 179,409 | 136,852 | 146,008 | 41,525 | 5,504 | 39,285 | -9,416 | -22,834 | 175,856 | |||||
Debtors | -325,310 | 315,087 | 317,578 | 238,626 | 24,330 | -276,948 | -38,656 | 272,656 | -54,625 | 111,074 | 170,736 | 31,868 | 18,949 | 20,159 | 25,636 |
Creditors | -69,978 | 122,953 | 11,587 | 156,786 | 95,442 | -76,278 | 9,312 | -32,216 | -151,698 | 191,839 | 122,884 | 8,315 | -28,368 | 5,260 | 38,015 |
Accruals and Deferred Income | 17,939 | 21,869 | -219,626 | 228,130 | -220,185 | -105,771 | 38,212 | 80,200 | 283,631 | -154,868 | 97,854 | 5,476 | 51,538 | ||
Deferred Taxes & Provisions | -16,177 | 3,510 | 20,041 | 27,643 | -11,778 | -7,593 | 14,454 | -223 | 4,953 | 190 | 1,172 | ||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 102,840 | ||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -83,000 | 40,000 | 43,000 | -18,217 | 18,217 | ||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -6,000 | 6,000 | -22,292 | -121,151 | -871 | 104,765 | 39,549 | ||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -1,094 | -1,094 | -1,094 | -1,541 | 49,127 | -28,524 | 8,693 | 19,831 | |||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 226,004 | 5,203 | -791,157 | 594,267 | -264,929 | 174,482 | 59,614 | -71,910 | 72,279 | 71,778 | 237,210 | 17,438 | 82,102 | 22,414 | 54,159 |
overdraft | -35,809 | 13,335 | -73,534 | 73,086 | 22,922 | ||||||||||
change in cash | 226,004 | 5,203 | -791,157 | 594,267 | -229,120 | 161,147 | 133,148 | -144,996 | 49,357 | 71,778 | 237,210 | 17,438 | 82,102 | 22,414 | 54,159 |
Perform a competitor analysis for chrysalis health & beauty business solutions ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in NG7 area or any other competitors across 12 key performance metrics.
CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD group structure
Chrysalis Health & Beauty Business Solutions Ltd has no subsidiary companies.
Ultimate parent company
1 parent
CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD
06233700
Chrysalis Health & Beauty Business Solutions Ltd currently has 2 directors. The longest serving directors include Mr Mark Broughton (May 2007) and Mrs Nicola Broughton (Jun 2024).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Mark Broughton | United Kingdom | 55 years | May 2007 | - | Director |
Mrs Nicola Broughton | United Kingdom | 51 years | Jun 2024 | - | Director |
P&L
March 2024turnover
5.1m
-6%
operating profit
43k
0%
gross margin
42.1%
+0.85%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
2.3m
+0.02%
total assets
2.9m
-0.01%
cash
489k
+0.86%
net assets
Total assets minus all liabilities
company number
06233700
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
10890 - Manufacture of other food products n.e.c.
incorporation date
May 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
creation house, 50-72 gauntley street, nottingham, NG7 5HF
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to chrysalis health & beauty business solutions ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CHRYSALIS HEALTH & BEAUTY BUSINESS SOLUTIONS LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|